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Agonist-induced changes in expression and mRNA levels of luteinizing hormone (LH) receptors were compared during stimulation of varian 
follicular maturation and luteinization by g adotropic hormones. Three major species of LH receptor mRNA, 5.8, 2.6 and 2.3 kb, were present 
throughout differentiation nd changed similarly, the 5.8 kb species being consistently more abundant than the smaller forms. The increased expres- 
sion of plasma-membrane LH receptors in preovulatory follicles and luteinized ovaries and their homologous down-regulation during follicular 
and luteal desensitization were closely correlated with the steady-state receptor mRNA l v ls. The reappearance of LH receptors following desensiti- 
zation during the luteal stage was preceded by an increase in mRNA levels. These studies have demonstrated that the expression of LH receptors 
during follicular maturation, ovulation and desensitization is related t  the prevailing levels of receptor mRNA in the ovary. 
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1. INTRODUCTION 
Gonadotropic  hormones exert their multiple tissue- 
specific effects on ovarian function i a temporal and 
concentration-dependent manner through specific 
receptors on ovarian cells. Follicle-stimulating hormone 
(FSH) stimulates follicular g owth and induces the ex- 
pression of  LH receptors in granulosa cells [1-4]. Such 
receptors have high binding affinity and specificity for 
LH  and hCG (human chorionic gonadotropin) and are 
sometimes referred to as LH/hCG receptors. Moderate 
and sustained increases of  serum LH facilitate the in- 
duction of  LH  receptors by FSH. However, the en- 
dogenous LH surge and administration of  an ovulatory 
dose of  hCG cause a temporary loss o f  LH receptors in 
ovulated follicles. A secondary increase in LH  receptors 
after induction of  ovulation by hCG occurs during 
follicular luteinization and formation of  corpora lutea 
[4]. 
The PMSG (pregnant mare serum gonadotropin) /  
hCG primed pseudopregnant rat is a well-established 
model for the study of  regulation of  ovarian functions 
by gonadotropins [5]. The intrinsic FSH and LH ac- 
tivities of  PMSG stimulate the granulosa cells of  small 
preantral follicles to grow and differentiate, with ac- 
quisition of  LH and prolactin receptors and aromatase 
activity. The subsequent administration of  an ovulatory 
dose of  hCG induces the antral follicles to ovulate and 
luteinize. About  8-10 days after PMSG treatment, the 
ovulated follicles become heavily luteinized and display 
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maximal increases in LH and prolactin receptors [6-8]. 
At this stage, further administration of  hCG causes a 
marked loss of  LH receptor sites, and desensitization of
LH-stimulated adenylate cyclase, cyclic AMP produc- 
tion, and steroidogenesis [6,9]. The developmental 
stage-specific regulation of  LH receptors is a relatively 
complex process, and could be associated with multiple 
mechanisms including receptor occupancy, hor- 
mone-receptor internalization, receptor unmasking, 
recycling, degradation, and synthesis. In the present 
study, we utilized the pseudopregnant rat model to in- 
vestigate the correlation between steady-state LH recep- 
tor mRNA levels and the expression of  receptor sites 
during various stages of  ovarian differentiation and 
homologous receptor down-regulation. Our results 
have demonstrated coordinate regulation of  LH  recep- 
tors and mRNA levels during gonadotropin- induced 
up-regulation and homologous down-regulation of  the 
ovarian receptor sites. 
2. MATERIALS  AND METHODS 
Ovaries were removed at various stages of hormone treatment as 
shown in Fig. l, for analysis of LH receptors and mRNA levels. Total 
ovarian RNA was prepared as described by Chirgwin et al. [10] and 
poly(A) ÷ RNA was selected by oligo(dT)-cellulose chromatography. 
Ovarian LH receptor cDNA was isolated from a size-selected ovarian 
cDNA library [11]. The library was screened with three end-labelled 
synthetic oligonucleotides (10 9 dpm//zg) based on regions of the 
recently cloned cDNA for the rat LH receptor [12] at positions 
108-81, 462-435 and 1227-1200. A full-length cDNA clone was 
characterized and used as the probe in this study. ForNorthern blot 
analyses, 7/zg of poly(A) ÷ RNA were denatured with glyoxal, resolv- 
ed in 1 °70 agarose gels, transferred to Zetabind nylon filters and subse- 
quently hybridized with random primed labelled full-length (2.4 kb) 
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Fig. 1. Diagram of the experimental design. 25-day old immature 
female rats (Sprague-Dawley) were injected subcutaneously (s.c.) at 
the time points indicated by arrows with 50 IU PMSG, followed by 
two injections of 25 IU hCG (lst and 2nd doses). Ovaries were remov- 
ed at specified times (bars). Overlapping points were allowed for the 
different groups. 
ovarian LH receptor cDNA (spec. act. 1-2 × 109 dpm/#g) for 18 h 
followed by autoradiography [11,13]. Subsequently, blots were strip- 
ped and rehybridized to an 0.6 kb 3-actin cDNA probe to normalize 
the quantization of specific LH receptor mRNA species. Radioac- 
tivities were quantitated from the blots with a Radioanalytic Imaging 
System (AMBIS Systems Inc., San Diego, CA). LH receptor binding 
capacity was derived from 125I-hCG binding studies in ovarian mem- 
branes, as previously described [14]. 
3. RESULTS AND DISCUSSION 
Northern blot analyses of ovarian poly(A) ÷ RNA 
using the LH receptor cDNA probe revealed that three 
major bands of 5.8, 2.6 and 2.3 kb, and a minor 4.4. kb 
band, were present at most stages of ovarian matura- 
tion, while three other minor species (8.0, 1.9 and 1.4 
kb) were only observed at certain developmental stages 
(Figs 1 and 2A-D). The immature ovary possesses low 
levels of both LH receptor mRNA and LH receptors (15 
fmol/ovary) (Fig. 3). After administration f PMSG, 
the levels of the major mRNA species (5.8, 2.6 and 2.3 
kb) were significantly elevated at 24 h and increased 
progressively to 14-fold above the untreated levels at 65 
h (Fig. 2A above; Fig. 3 below). One of the minor 
mRNA species, the 4.4. kb band, was present in un- 
treated immature ovaries and increased with the major 
mRNAs, while the 1.4 and 1.9 kb bands were barely 
detectable at 48 and 65 h after PMSG administration. 
The LH receptors showed an initial significant decrease 
at 5 h, probably due to occupancy by the exogenous 
gonadotropin, and then increased in parallel with the 
mRNA changes and reached maximal levels of 5-fold 
above pretreatment values at 65 h (Fig. 3, above). 
After administration f an ovulatory (first) dose of 
hCG, receptor mRNA levels declined by 50°7o within the 
first 34 h (Fig. 2A and Fig. 3, below). This was followed 
by a marked and progressive increase to reach maximal 
levels of the more abundant mRNA species, as well as 
the minor 4.4, 1.9 and 1.4 kb bands, 6 days after the 1st 
hCG injection. At days 4 and 6, an additional band of 
8.8 kb was observed (Fig. 2B). This species was barely 
detectable 65 h after PMSG injection and two days after 
the initial ovulatory dose of hCG. These changes in 
mRNA levels were accompanied by an initial decrease 
in 125I-hCG binding within 34 h, followed by pro- 
gressive increases at 4 and 6 days to levels of 4000 fmol 
per ovary at the time of maximal luteinization (Fig. 3, 
above). 
Administration of a second (desensitizing) dose of 
hCG caused a sharp decrease in LH receptor mRNA 
from 6 h to almost undetectable levels at 24 h (Fig. 
2C,D), with partial recovery during the following two 
days. The LH receptors also declined markedly, to one- 
tenth of the binding capacity observed at the peak of 
luteinization. Minor recovery occurred during the 
following 4 days (Fig. 3), when receptors levels began to 
increase (P<0.01) and returned to the levels (not 
shown, [6]) observed in heavily luteinized ovaries 8-10 
days after the first dose of hCG (Fig. 3, below). 
The up-regulation 9f LH receptors in preovulatory 
follicles and luteinized ovaries, and their down- 
regulation during follicular and luteal desensitization, 
were closely associated with the steady-state receptor 
mRNA levels. However, the rate of the increase in LH 
receptors after the 1st hCG dose was 2-fold greater than 
that of mRNA (0.0288 vs 0.0142, 0.0135 cpm.h-1), in- 
dicating that hormone-stimulated variations in cell- 
surface receptor number are not solely dependent on de 
novo synthesis. 
Fluctuations in the concentrations of the major 5.8, 
2.6 and 2.3 kb mRNA species during follicular develop- 
ment (after PMSG injection) and subsequent luteiniza- 
tion (after 1st hCG dose) were also significantly cor- 
related (r=0.240 + 0.0391 and 0.263 + 0.032, respec- 
tively). The levels of the 5.8 kb species were significant- 
ly higher (4.6 + 1.3 (_+ SD)-fold) than those of the 2.3 
and 2.6 species (Fig. 3, below). However, the ratio be- 
tween the 5.8 and 2.6 plus 2.3 kb species did not vary 
significantly, indicating that hormonal treatment did 
not differentially affect the larger and smaller forms. 
The increase in 5.8 kb mRNA following the marked 
down-regulation caused by the desensitizing (2nd) dose 
of hCG was more pronounced than that observed for 
the smaller forms. The increase in both mRNAs was 
followed by a modest rise in receptors that was signifi- 
cant on the 4th day after the 2nd hCG dose (Fig. 3, 
above) and continued to rise thereafter as previously 
demonstrated [6]. The delay in appearance of receptors 
in this case could be attributed to induction of luteiniza- 
tion in a further group of mature follicles. 
Although the function of these individual mRNA 
species and their translatable potential to form mature 
receptor protein is not yet known, it is possible that the 
larger forms (8.8, 5.8 and 4.4. kb) are precursor mRNA 
forms while the smaller species (2.6, 2.3, 1.9 and 1.4 kb) 
represent mature messages. Also, some or all species 
could arise from alternative splicing since the LH recep- 
tor gene, in contrast to the 3-adrenergic and most other 
G-protein receptors, has at least several introns located 
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Fig. 2. Northern blot analyses of LH receptor mRNA. (Upper panel) Shows the autoradiographs (A and B) of ovarian LH receptor mRNAs during 
follicular development, superovulation a d luteinization. Lanes are: (A) 0 (control), 9, 24, 48 and 65 h following PMSG treatment; 34 h after hCG 
(lst dose); (B) 0 (65 h after PMSG), 2, 4, and 6 days after 1st hCG dose and 24 h after 2nd hCG dose. (Lower panel) Shows the autoradiographs 
(C and D) of LH receptor mRNAs of luteinized ovaries at 0-72 h following the 2nd hCG dose. RNA standards are indicated on the right, and 
the deduced sizes of mRNA species on the left side of each blot. On the bottom of each blot are shown the corresponding/~-actin mRNA levels. 
within sequences coding for the extracellular domain of 
the receptors [15,16]. Several cDNA species have been 
isolated from pig and rat testicular and ovarian libraries 
including a 2.1 kb cDNA lacking sequences that code 
for transmembrane regions [15-17]. Genomic analysis 
of the LH receptor gene indicates that this species is a 
product of alternative splicing [15]. 
The concentration-dependent and developmental 
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Fig. 3. Changes in LH/hCG receptor binding capacity and steady- 
state receptor mRNA levels. The upper panel shows the binding of 
tzSI-hCG to the membrane preparation from various stages of 
pseudopregnant ra ovaries. Each value is the mean + SE (fmol per 
ovary, n = 3). The lower panel shows the quantitation f LH receptor 
mRNAs expressed as dpm/ovary normalized to the corresponding/3- 
actin mRNA. (O---e) represents 5.8 kb LH receptor mRNA; 
(-" -') represents 2.6 + 2.3 kb LH receptor mRNA. Bars indicate 
mean ± SE of triplicate or mean ± range of duplicate blot analyses. 
Similar profiles were observed with mRNA/actin ratios. 
stage-specif ic actions of  gonadotrop ins  indicate the 
complexi ty  of  the regulatory mechanisms operat ing in 
gonadal  target cells. Low concentrat ions of  hCG cause 
up-regulat ion of  LH  receptors in granulosa cells of  
preovulatory follicles [1] and in Leydig cells of  the testis 
[18]. In contrast,  high doses of  hCG cause pro found 
down-regulat ion of LH receptors and desensit ization f
adenylate cyclase in luteinized cells of  pseudopregnant  
rat ovaries and mature Leydig cells, but up-regulate LH 
receptors in the fetal populat ion  o f  Leydig cells [6,18]. 
LH  and FSH receptors are coupled to the guanyl 
nucleot ide regulatory protein,  Gs, and exert their ac- 
t ions mainly through cAMP-dependent  mechanisms 
[3,19]. Cyclic AMP is a transcr ipt ional  regulator and 
may play diverse roles through act ivat ion of  specific 
regulators at di f ferent stages o f  di f ferent iat ion.  
E luc idat ion of  the gene structure of  the LH receptor 
will permit  more detai led analysis o f  homologous and 
heterologous receptor egulat ion at the transcr ipt ional  
level, and the def init ion of  changes that result f rom 
mRNA processing and/or  degradat ion at individual  
stages of  ovar ian development.  These studies have 
demonstrated that gonadotrop in- induced xpression, 
up-regulat ion and down-regulat ion of LH receptors are 
highly correlated with the levels of  LH  receptor mRNA 
in the ovary. 
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